Greenspring Advisors LLC Sells 60 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Greenspring Advisors LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 482 shares of the healthcare conglomerate’s stock after selling 60 shares during the quarter. Greenspring Advisors LLC’s holdings in UnitedHealth Group were worth $244,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the third quarter worth about $27,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. West Financial Advisors LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth about $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth approximately $37,000. Finally, Friedenthal Financial bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $51,000. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

NYSE:UNH opened at $539.50 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm’s 50-day simple moving average is $532.43 and its 200 day simple moving average is $564.77. The firm has a market cap of $496.49 billion, a price-to-earnings ratio of 34.81, a P/E/G ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.